Skip to main content
Premium Trial:

Request an Annual Quote

Definiens' Biomarker Datafication Services for Oncology

Definiens has launched a suite of biomarker datafication services for oncology clinical development programs. These services will enable pharmaceutical and biotech companies gather comprehensive data from tissue samples that they can use to make decisions about which drug candidates to advance as well as assess the potential of companion diagnostics for patient stratification. Through the service, users gain access to data such as biomarker expression profiles, biological response to therapy and continuous biomarker readouts enabling advanced decision making and data analysis.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.